Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bohai Pharmaceuticals Group Inc. (OTC: BOPH).

Full DD Report for BOPH

You must become a subscriber to view this report.

Recent News from (OTC: BOPH)

SEC Suspension of Trading
SEC Suspension of Trading
Source: OTC Markets
Date: September, 06 2017 00:00
Seeking Alpha's Biotech Weekly: J&J-Achillion Vs. Gilead, MannKind's Marketing, And More
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. In a tumultuous week, there was plenty for investors to grapple with. Johnson & Johnson (NYSE: JNJ ) inked a deal with...
Source: SeekingAlpha
Date: May, 22 2015 16:00
What Have We Learned From Bohai Pharmaceuticals?
Back in June 17, 2014, I wrote an article titled " Why Doesn't Bohai Pharmaceuticals Go Up? " In this article, with Bohai Pharmaceuticals ( OTCPK:BOPH ) trading for just $1.40 on 9M earnings of $0.85 and growing revenues quickly, I explained what the bear thesis was. Or, in other words, why BO...
Source: SeekingAlpha
Date: May, 16 2015 13:54


About Bohai Pharmaceuticals Group Inc. (OTC: BOPH)

Logo for Bohai Pharmaceuticals Group Inc. (OTC: BOPH)

Not available


Contact Information



Current Management

  • Hongwei Qui / President, CEO
  • Chunhong Jiang / Secretary, Treasurer
  • Hongwei Qui / Chairman
  • Thomas Tan /

Current Share Structure

  • Market Cap: $5,806 - 03/13/2018
  • Issue and Outstanding: 19,352,914 - 10/14/2014


Daily Technical Chart for (OTC: BOPH)

Daily Technical Chart for (OTC: BOPH)

Stay tuned for daily updates and more on (OTC: BOPH)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BOPH)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

The Subway Trader



Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BOPH is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of BOPH and does not buy, sell, or trade any shares of BOPH. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: